Immunic, Inc.
IMUX· Nasdaq
IMUXImmunic, Inc.
Filed Aug 8, 2019 · 10-Q · 39 days after period end · 0001280776-19-000051
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Net Income | -$14.71M | -$2.67M | -$12.41M | -$9.47M |
| EPS Diluted | -$1.52 | -$3.15 | -$0.29 | -$0.30 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR
ended Jun 30, 2019 · filed Aug 8, 2019 · 39 d after period end
